Lizhen Xu

4.3k total citations · 1 hit paper
68 papers, 1.5k citations indexed

About

Lizhen Xu is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Sensory Systems. According to data from OpenAlex, Lizhen Xu has authored 68 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 13 papers in Cardiology and Cardiovascular Medicine and 11 papers in Sensory Systems. Recurrent topics in Lizhen Xu's work include Ion Channels and Receptors (11 papers), Atrial Fibrillation Management and Outcomes (10 papers) and Nanoplatforms for cancer theranostics (7 papers). Lizhen Xu is often cited by papers focused on Ion Channels and Receptors (11 papers), Atrial Fibrillation Management and Outcomes (10 papers) and Nanoplatforms for cancer theranostics (7 papers). Lizhen Xu collaborates with scholars based in China, United States and Canada. Lizhen Xu's co-authors include Andrew D. Paterson, Wei Xu, Williams Turpin, Fan Yang, Wenqiang Chen, Chusheng Huang, Jun Huang, Jiarong Sheng, Xiangzhi Song and Shilong Yang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Angewandte Chemie International Edition and Nature Communications.

In The Last Decade

Lizhen Xu

63 papers receiving 1.5k citations

Hit Papers

Association of host genome with intestinal microbial comp... 2016 2026 2019 2022 2016 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lizhen Xu China 20 606 219 209 170 145 68 1.5k
Tanja Maier Germany 28 974 1.6× 64 0.3× 46 0.2× 211 1.2× 164 1.1× 65 2.5k
De‐Ming Yang Taiwan 23 754 1.2× 34 0.2× 65 0.3× 38 0.2× 83 0.6× 90 2.0k
Fumio Inoue Japan 19 395 0.7× 62 0.3× 50 0.2× 100 0.6× 68 0.5× 94 1.3k
Warren F. Diven United States 28 619 1.0× 105 0.5× 123 0.6× 34 0.2× 43 0.3× 96 2.1k
Mario Ollero France 33 878 1.4× 136 0.6× 175 0.8× 17 0.1× 223 1.5× 88 3.5k
Mayumi Watanabe Japan 25 734 1.2× 80 0.4× 31 0.1× 19 0.1× 95 0.7× 138 1.9k
Jay R. Thiagarajah United States 32 1.9k 3.1× 50 0.2× 27 0.1× 151 0.9× 336 2.3× 64 3.8k
Hyun Ju Yoo South Korea 29 1.2k 1.9× 149 0.7× 187 0.9× 9 0.1× 129 0.9× 111 2.5k
Maureen D. Donovan United States 23 409 0.7× 39 0.2× 24 0.1× 65 0.4× 53 0.4× 55 1.7k
Nadia Mores Italy 28 512 0.8× 31 0.1× 70 0.3× 39 0.2× 214 1.5× 95 2.2k

Countries citing papers authored by Lizhen Xu

Since Specialization
Citations

This map shows the geographic impact of Lizhen Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lizhen Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lizhen Xu more than expected).

Fields of papers citing papers by Lizhen Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lizhen Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lizhen Xu. The network helps show where Lizhen Xu may publish in the future.

Co-authorship network of co-authors of Lizhen Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Lizhen Xu. A scholar is included among the top collaborators of Lizhen Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lizhen Xu. Lizhen Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Xu, Lizhen, et al.. (2025). All in one: An in-situ activated tumor theranostic agent for NIR-II fluorescence imaging guided surgical resection and photothermal therapy. Chinese Chemical Letters. 36(11). 110850–110850. 2 indexed citations
4.
Li, Yanling, Jianfeng Xu, Fuhai Liu, et al.. (2024). Design and Analysis of Terahertz Wave Tunable Metamaterial with High Refractive Index. Silicon. 16(11). 4621–4633. 1 indexed citations
5.
Chen, Chih‐Hao, Ashkan Shoamanesh, Pablo Colorado, et al.. (2024). Hemorrhagic Transformation in Noncardioembolic Acute Ischemic Stroke: MRI Analysis From PACIFIC-STROKE. Stroke. 55(6). 1477–1488. 2 indexed citations
6.
Liang, Xing, et al.. (2024). Development of a novel NIR-II fluorescence probe for monitoring serum albumin fluctuation in cerebra neurotoxicity induced by manganese exposure. Journal of Hazardous Materials. 485. 136936–136936. 2 indexed citations
7.
Ma, Yanyan, et al.. (2024). Peroxynitrite activatable NIR-II probe for tumor diagnosis and photothermal therapy in vivo. Analytica Chimica Acta. 1335. 343443–343443. 1 indexed citations
8.
Wang, Yan, Lizhen Xu, Ying Zhang, et al.. (2023). Dent disease 1-linked novel CLCN5 mutations result in aberrant location and reduced ion currents. International Journal of Biological Macromolecules. 257(Pt 2). 128564–128564. 3 indexed citations
9.
Xu, Lizhen, et al.. (2023). Real-time monitoring norepinephrine exocytosis by high K+via an endoplasmic reticulum-targeting fluorescent probe. Journal of Materials Chemistry B. 11(23). 5117–5122. 7 indexed citations
10.
Concha, Mauricio, Lizhen Xu, MacKenzie Horn, et al.. (2023). Predictors of Intracranial Hemorrhage Volume Expansion in Patients Receiving Factor Xa Inhibitors in ANNEXA‐4: Time and Severity Matter Most. SHILAP Revista de lepidopterología. 4(1). e000997–e000997. 4 indexed citations
11.
Zhao, Cheng, Yuan Xie, Lizhen Xu, et al.. (2022). Structures of a mammalian TRPM8 in closed state. Nature Communications. 13(1). 3113–3113. 34 indexed citations
12.
Demchuk, Andrew M., Patrick Yue, Elena Zotova, et al.. (2021). Hemostatic Efficacy and Anti-FXa (Factor Xa) Reversal With Andexanet Alfa in Intracranial Hemorrhage: ANNEXA-4 Substudy. Stroke. 52(6). 2096–2105. 43 indexed citations
13.
Benz, Alexander P., Lizhen Xu, John W. Eikelboom, et al.. (2021). Abstract P3: Andexanet Alfa for Acute Bleeding During Treatment With Edoxaban. Stroke. 52(Suppl_1). 1 indexed citations
14.
Luo, Lei, Yunfei Wang, Bowen Li, et al.. (2020). Author Correction: Molecular basis for heat desensitization of TRPV1 ion channels. Nature Communications. 11(1). 1798–1798. 1 indexed citations
15.
Zhang, Bo, Lizhen Xu, Ningning Li, et al.. (2020). Cooperative transport mechanism of human monocarboxylate transporter 2. Nature Communications. 11(1). 2429–2429. 48 indexed citations
16.
Luo, Lei, Bowen Li, Lizhen Xu, et al.. (2019). Molecular basis for heat desensitization of TRPV1 ion channels. Nature Communications. 10(1). 2134–2134. 56 indexed citations
17.
Yao, Tony, Rohan John, Amirreza Haghighi, et al.. (2019). Integration of Genetic Testing and Pathology for the Diagnosis of Adults with FSGS. Clinical Journal of the American Society of Nephrology. 14(2). 213–223. 90 indexed citations
18.
Panjwani, Naim, Lizhen Xu, Jiafen Gong, et al.. (2018). Improving imputation in disease-relevant regions: lessons from cystic fibrosis. npj Genomic Medicine. 3(1). 8–8. 5 indexed citations
19.
Xu, Lizhen, Radu V. Craiu, Lei Sun, & Andrew D. Paterson. (2014). Parameter Expanded Algorithms for Bayesian Latent Variable Modeling of Genetic Pleiotropy Data. Journal of Computational and Graphical Statistics. 25(2). 405–425. 2 indexed citations
20.
Ni, Weiwei, et al.. (2010). Approximate K-Median of Location Streams with Redundancy and Inconsistency.. 4. 165–182. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026